Constellation Brands Reports Third Quarter Fiscal 2026 Financial Results GlobeNewswire January 07, 2026 ROCHESTER, N.Y., Jan. 07, 2026 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its third quarter fiscal 2026 financial results. A conference call to discuss the financial results and outlook will be hosted by President […]

Bitfarms to Present at Needham Growth Conference in NYC GlobeNewswire January 07, 2026 TORONTO, Ontario and NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — Bitfarms Ltd. (NASDAQ/TSX: BITF), a North American energy and digital infrastructure company, will participate in Needham's 28th Annual Growth Conference, taking place from January 13-14 in New York City. A management

RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 07, 2026 SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that

iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation GlobeNewswire January 07, 2026 NASHVILLE, Tenn., Jan. 07, 2026 (GLOBE NEWSWIRE) — Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today announced members of its management team will participate in the following investor conferences this winter, which will include hosting meetings around the annual J.P. Morgan

Ultragenyx to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 07, 2026 NOVATO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D.,

Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 07, 2026 SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Jane Chung, Chief Executive Officer,

Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis Investor call to be held January 8 at 4:30 pm ET to discuss data update and next steps GlobeNewswire January 07, 2026 PITTSBURGH, Jan. 07, 2026 (GLOBE NEWSWIRE) — Krystal Biotech, Inc.

INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP announces that Firefly Aerospace Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire January 07, 2026 SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Firefly Aerospace Inc. (NASDAQ: FLY):

Ethan Allen Announces Release Date for its Fiscal 2026 Second Quarter Results GlobeNewswire January 07, 2026 DANBURY, CT, Jan. 07, 2026 (GLOBE NEWSWIRE) — Ethan Allen Interiors Inc. (“Ethan Allen” or the “Company”) (NYSE: ETD) will release its financial and operational results for the fiscal 2026 second quarter ended December 31, 2025, after the stock

Abivax Provides 2026 Corporate Outlook GlobeNewswire January 07, 2026 Abivax Provides 2026 Corporate Outlook New market insights indicate significant future expansion of the ulcerative colitis (UC) market, with obefazimod well positioned to become a future market leader in the IBD space ABTECT Phase 3 Data Safety Monitoring Board (DSMB) meeting on December 18, 2025, found